Adverse Reactions to Drugs

Content: 
Front Matter, Page iii
Copyright, Page iv
PREFACE TO THE SECOND EDITION, Pages vii-viii
ACKNOWLEDGMENTS, Page ix
CHAPTER I - THE DAWN OF CONCERN, Pages 1-9
CHAPTER II - ADVERSE REACTIONS, Pages 10-22
CHAPTER III - FACTORS WHICH PREDISPOSE TO ADVERSE DRUG REACTIONS, Pages 23-38
CHAPTER IV - DRUG INTERACTIONS, Pages 39-58
CHAPTER V - ADVERSE REACTIONS IN DENTAL PRACTICE, Pages 59-65
CHAPTER VI - DRUGS USED IN PREGNANCY, THE NEONATE AND LACTATION, Pages 66-71
CHAPTER VII - PROBLEMS FOR THE PHARMACEUTICAL INDUSTRY BEFORE MARKETING A NEW DRUG, Pages 72-82
CHAPTER VIII - MONITORING ADVERSE REACTIONS TO DRUGS AND THE THERAPEUTIC AUDIT, Pages 83-106
CHAPTER IX - DRUG REGULATORY BODIES AND THEIR PROBLEMS, Pages 107-119
CHAPTER X - THE FUTURE, Pages 120-125
APPENDIX I - ADVERSE REACTIONS TO DRUGS, Pages 126-155
APPENDIX II - DRUG INDUCED DISEASE, Pages 156-176
APPENDIX III - DRUG INTERACTION TABLES, Pages 177-189
APPENDIX IV - DRUGS IN PREGNANCY, Pages 190-200
REFERENCES, Pages 201-207
INDEX, Pages 209-217
DRUG INDEX, Pages 219-230